female infertility. Female infertility, unspecified
Conditions
Interventions
Intervention 1: control group receive 6500 I.U hCG IM for triggering final oocyte maturation . Intervention 2: Intervention group receive 6500 I.U. IM hCG+triptorelin0.2mg/sc for triggering.
Sponsors
shahid sadoughi university of medical sciences
Eligibility
Sex/Gender
Female
Age
No minimum to 42 Years
Inclusion criteria
Inclusion criteria: normal responder women by tubal or male infertility factor, 18< Body mass index <30 kg/m2, and age =42 yr with the history of infertility for at least 1 yr that were candidate for ART protocol
Exclusion criteria
Exclusion criteria: the presence of endocrine disorders such as diabetes mellitus, hyperprolactinemia, thyroid disorders, congenital adrenal hyperplasia, Cushing syndrome, polycystic ovary syndrome, congenital uterine anomaliesdisorders, repeated implantation failure, day-3 FSH concentration =10 IU/L or serum anti-Mullerian hormone =1.0 ng/mL, and azoospermia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy rate. Timepoint: 28 days after transfer. Method of measurement: vaginal sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Chemical pregnancy rate. Timepoint: 14 days after transfer. Method of measurement: BhCG test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Eftekhar
Yazd University of Medical Sciences
Outcome results
None listed